Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Operating Leases (2022 - 2025)

Celularity has reported Operating Leases over the past 4 years, most recently at $26.8 million for Q3 2025.

  • Quarterly results put Operating Leases at $26.8 million for Q3 2025, up 1.34% from a year ago — trailing twelve months through Sep 2025 was $26.8 million (up 1.34% YoY), and the annual figure for FY2024 was $26.5 million, up 1.42%.
  • Operating Leases for Q3 2025 was $26.8 million at Celularity, roughly flat from $26.7 million in the prior quarter.
  • Over the last five years, Operating Leases for CELU hit a ceiling of $30.5 million in Q1 2022 and a floor of $26.1 million in Q3 2023.
  • Median Operating Leases over the past 4 years was $26.7 million (2025), compared with a mean of $27.2 million.
  • Biggest five-year swings in Operating Leases: fell 7.92% in 2023 and later increased 1.45% in 2024.
  • Celularity's Operating Leases stood at $28.0 million in 2022, then fell by 6.46% to $26.2 million in 2023, then grew by 1.42% to $26.5 million in 2024, then increased by 0.97% to $26.8 million in 2025.
  • The last three reported values for Operating Leases were $26.8 million (Q3 2025), $26.7 million (Q2 2025), and $26.6 million (Q1 2025) per Business Quant data.